What is Nasal Strip Market?
A nasal strip is like a Band-Aid with a flexible backbone that holds the nostrils open when the strip is stuck across the bridge of the nose. Nasal strips have been shown to be easy to use and without deleterious side effects. People with snoring problems are increasingly preferring nasal strips since it overcomes the need for surgery. Apart from that, nasal strips are also used on a regular basis by athletes to enhance breathing during the game. About 37 million Americans snore on a regular basis, according to the National Sleep Foundation. Degrading lifestyles and increasing obesity are causing the numbers to rise further. Therefore, the demand for anti-snoring devices is expected to witness growth.
The market study is being classified, by Application (Kids, Teens and Adults) and major geographies with country level break-up.
GlaxoSmithKline (United Kingdom), Airboost (Australia), Bestmed, LLC (United States), Suzhou Sinomed (China), Laboratoire TRADIPHAR (France), Rhinomed (Australia), Splintek, Inc. (United States) and Theravent, Inc. (United States) are some of the key players profiled in the study.
Research Analyst at AMA predicts that United States Vendors will contribute to the maximum growth of Global Nasal Strip market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Nasal Strip market by Type, Application and Region.
On the basis of geography, the market of Nasal Strip has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- High Snoring Rates among People Worldwide
- Provides an Alternative to Surgical Intervention
Restraints
- Stringent Government Regulations to Ensure Product Safety
Opportunities
- Awareness Regarding Health Risks Such As Heart Diseases, Strokes Caused By Snoring
- Changing Lifestyle Causing Sleep Disorders among People Worldwide
Challenges
- Availability of Alternative Anti-Snoring Devices
FDA has laid down special controls, combined with the general controls, to provide assurance of the safety and effectiveness of devices for snoring and/or obstructive sleep apnea. Thus, a manufacturer who intends to market a device of this generic type should (1) conform to the general controls of the Federal Food, Drug & Cosmetic Act (the Act), including the premarket notification requirements described in 21 CFR 807 Subpart E, (2) address the specific risks to health associated with devices for snoring and/or obstructive sleep apnea identified in this guidance and, (3) obtain a substantial equivalence determination from FDA prior to marketing the device.
Key Target Audience
Nasal Strip Manufacturer, Healthcare Industry, Raw Material Supplier, End-User, Distributor and Supplier and Others